-
Tilray Analysts On The Sidelines Despite Solid Earnings
Thursday, February 18, 2021 - 12:47pm | 442Read More...Canadian cannabis companies Tilray Inc. (NASDAQ: TLRY) and Aphria Inc. (NASDAQ: APHA) have agreed to a merger. Meanwhile, Tilray announced strong fourth-quarter results, with meaningful revenue growth and margin expansion. The Tilray Analysts: Michael Lavery of Piper Sandler downgraded...
-
Piper Sandler Likes Tyson Foods As A Reopening Play
Thursday, December 3, 2020 - 11:35am | 295Read More...Tyson Foods, Inc. (NYSE: TSN) could be considered an economic reopening play due to the company's large exposure to the foodservice category, according to Piper Sandler. The Tyson Foods Analyst: Michael Lavery upgraded Tyson Foods from Neutral to Overweight with a price target lifted from $70...
-
Beyond Meat Analysts Debate If The Stock Now Has Big Opportunity Or Major Headwinds
Tuesday, November 10, 2020 - 12:17pm | 510Read More...Plant-based food maker Beyond Meat Inc (NASDAQ: BYND) reported third-quarter earnings that notably fell short of expectations and sparked a debate among analysts. The Analysts: CFRA analyst Arun Sundaram maintains a Sell rating on Beyond Meat's stock with a price target lowered from $100 to $80...
-
Cannabis Analysts From Piper Sandler, Jefferies, Cowen On Their Favorite Companies, Investments
Monday, June 8, 2020 - 3:31pm | 1045Read More...Some of the most high-profile cannabis analysts shared their insights in a thrilling discussion about trends, strategies and forecasts at the Virtual Benzinga Cannabis Capital Conference. Alan Brochstein, the founder of 420 Investor and New Cannabis Ventures, led the discussion. Cresco, Green Thumb...
-
Aurora Cannabis Shares Soar On Sales Beat: 'A Case Of The Patient Being Presumed Dead, When Indeed It's Not'
Friday, May 15, 2020 - 10:30am | 618Read More...Aurora Cannabis Inc (NYSE: ACB)(TSE:ACB) reported a 35% sequential sales increase for the third quarter to far exceed analyst expectations. While its EBITDA loss was about $10 million worse than consensus forecasted, international medical sales and Canadian recreational sales beat estimates,...
-
Hershey Analyst Turns Bullish As Retail Sales Rise
Wednesday, March 25, 2020 - 11:02am | 412Read More...Piper Sandler's prior cautious stance on Hershey Co (NYSE: HSY) was based on valuation concerns, and the stock's 24% decline since March now supports a bullish tone, the sell-side firm said this week. The Hershey Analyst Michael Lavery upgraded Hershey Company from Underweight to...
-
2 Beyond Meat Analysts On Q4 Results: 'Significant Downside Exists'
Friday, February 28, 2020 - 2:57pm | 509Read More...Plant-based food maker Beyond Meat Inc (NASDAQ: BYND) reported fourth-quarter results Thusday that showed "solid" momentum, but its near-term outlook remains unclear, according to Piper Sandler. The Beyond Meat Analysts Piper Sandler's Michael Lavery maintaied a Neutral...
-
This Beyond Meat Consumer Survey Highlights Some Challenges, Analyst Says
Wednesday, February 12, 2020 - 9:33am | 380Read More...The bullish case for plant-based food maker Beyond Meat Inc (NASDAQ: BYND) can't be justified amid mixed consumer survey results, according to Piper Sandler. The Beyond Meat Analyst Michael Lavery initiated coverage of Beyond Meat's stock with a Neutral rating and $115 price target. The...
-
Aurora Cannabis Downgraded By Piper Sandler, BofA
Friday, January 10, 2020 - 10:43am | 424Read More...Over the last 12 months, Aurora Cannabis Inc. (NYSE: ACB) shares have fallen 70%. Two sell-side analysts turned bearish on the cannabis stock Friday. The Aurora Analysts Piper Sandler analyst Michael Lavery downgraded Aurora Cannabis from Neutral to Underweight and lowered the price target...
-
Analyst: Canopy Growth Can Outlast Near-Term Headwinds
Tuesday, October 1, 2019 - 12:55pm | 399Read More...Canopy Growth Corp (NYSE: CGC) shares are down nearly 50% in the past six months, but one analyst said Tuesday the company and its patient investors will ultimately be able to ride out the near-term headwinds in the cannabis space. The Analyst Piper Jaffray analyst Michael Lavery reiterated his...
-
Potential No-Premium Deal Raises Questions On Altria's Outlook, This Analyst Moves Aside
Tuesday, September 10, 2019 - 11:23am | 344Read More...Altria Group Inc (NYSE: MO) is in talks with Philip Morris International Inc. (NYSE: PM) for a merger with no premium. The absence of a premium suggests that Altria’s underlying fundamentals and management's outlook for the company’s future may be worse than was earlier anticipated...
-
Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation'
Tuesday, August 13, 2019 - 1:06pm | 442Read More...Cannabis stocks got a boost on Tuesday after a major Wall Street firm initiated bullish coverage of Cronos Group Inc (NASDAQ: CRON). The Analyst Piper Jaffray analyst Michael Lavery initiated coverage of Cronos with an Overweight rating and $18 price target. The Thesis Lavery said Cronos is well...
-
Analyst: Trump Could Push Cannabis Legalization In 2020
Monday, June 10, 2019 - 1:55pm | 373Read More...Cannabis could be one of the top five issues in the 2020 presidential election, Piper Jaffray. President Donald Trump may champion legalization as a way of gaining favor with younger voters, the sell-side firm said in a Sunday note. Need more cannabis news? Check out all of our coverage here...
-
Piper Jaffray: Tilray, GW Pharma Are Early Leaders In Medical Cannabis
Tuesday, March 5, 2019 - 2:13pm | 525Read More...Cannabis stocks have been red-hot so far in 2019, and Piper Jaffray analyst Michael Lavery said Monday that the outlook for medical cannabis is brighter than ever. Lavery recently met with a pain specialist to determine how much of an impact medical marijuana could have on the business of pain...
-
Piper Jaffray Sees More Upside In Canopy Growth On Geographic, Product Expansion
Friday, January 25, 2019 - 8:49am | 392Read More...Canopy Growth Corp (NYSE: CGC) kicked off 2019 with a 53-percent run. It hasn’t even begun to strike its high, according to one analyst team. The Rating Piper Jaffray analysts Michael Lavery and Jeffrey Kratky maintained an Overweight rating on Canopy Growth and raised their price target from...
